109 related articles for article (PubMed ID: 22130459)
1. Pharmacokinetics of intravenous and intramuscular parecoxib in healthy Beagles.
Giorgi M; Saccomanni G; Del Carlo S; Manera C; Lavy E
Vet J; 2012 Jul; 193(1):246-50. PubMed ID: 22130459
[TBL] [Abstract][Full Text] [Related]
2. Development of a population pharmacokinetic model for parecoxib and its active metabolite valdecoxib after parenteral parecoxib administration in children.
Hullett B; Salman S; O'Halloran SJ; Peirce D; Davies K; Ilett KF
Anesthesiology; 2012 May; 116(5):1124-33. PubMed ID: 22450476
[TBL] [Abstract][Full Text] [Related]
3. Transfer of parecoxib and its primary active metabolite valdecoxib via transitional breastmilk following intravenous parecoxib use after cesarean delivery: a comparison of naive pooled data analysis and nonlinear mixed-effects modeling.
Paech MJ; Salman S; Ilett KF; O'Halloran SJ; Muchatuta NA
Anesth Analg; 2012 Apr; 114(4):837-44. PubMed ID: 22344242
[TBL] [Abstract][Full Text] [Related]
4. Determination of valdecoxib in serum using a HPLC-diode array detector and its application in a pharmacokinetic study.
Keshetty S; Venisetty RK; Molmoori V; Ciddi V
Pharmazie; 2006 Mar; 61(3):245-6. PubMed ID: 16599270
[TBL] [Abstract][Full Text] [Related]
5. Effects of Dexmedetomidine on the Pharmacokinetics of Parecoxib and Its Metabolite Valdecoxib in Beagles by UPLC-MS/MS.
Hu J; Lv BF; Guo WJ; Wang BW; Miao D; Qiu XJ; Chen XP
Biomed Res Int; 2020; 2020():1563874. PubMed ID: 32832543
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous detection and quantification of parecoxib and valdecoxib in canine plasma by HPLC with spectrofluorimetric detection: development and validation of a new methodology.
Saccomanni G; Giorgi M; Del Carlo S; Manera C; Saba A; Macchia M
Anal Bioanal Chem; 2011 Sep; 401(5):1677-84. PubMed ID: 21769548
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous Determination of Parecoxib and Its Metabolite Valdecoxib Concentrations in Beagle Plasma by UPLC-MS/MS and Application for Pharmacokinetics Study.
Li SL; Zhu YL; Zhu CY; Li SB; Li ZH; Qiu XJ
Drug Des Devel Ther; 2020; 14():1117-1125. PubMed ID: 32214797
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of parecoxib and its main metabolites valdecoxib and hydroxylated valdecoxib in mouse plasma with a sensitive LC-MS/MS method to elucidate the decreased drug metabolism of tumor bearing mice.
Jin X; Zhou F; Liu Y; Cheng C; Yao L; Jia Y; Wang G; Zhang J
J Pharm Biomed Anal; 2018 Sep; 158():1-7. PubMed ID: 29843006
[TBL] [Abstract][Full Text] [Related]
9. Determination of parecoxib and valdecoxib in rat plasma by UPLC-MS/MS and its application to pharmacokinetics studies.
Chen M; Sun W; Wang Z; Huang C; Hu G; Chen Y; Wang L
BMC Pharmacol Toxicol; 2020 Apr; 21(1):27. PubMed ID: 32264977
[TBL] [Abstract][Full Text] [Related]
10. Presurgical intravenous parecoxib sodium and follow-up oral valdecoxib for pain management after laparoscopic cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects.
Gan TJ; Joshi GP; Zhao SZ; Hanna DB; Cheung RY; Chen C
Acta Anaesthesiol Scand; 2004 Oct; 48(9):1194-207. PubMed ID: 15352969
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of intramuscular microparticle depot of valdecoxib in an experimental model.
Agnihotri SM; Vavia PR
Drug Dev Ind Pharm; 2009 Sep; 35(9):1043-7. PubMed ID: 19365783
[TBL] [Abstract][Full Text] [Related]
12. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
13. A pharmacokinetic study of intramuscular (i.m.) parecoxib sodium in normal subjects.
Karim A; Laurent A; Slater ME; Kuss ME; Qian J; Crosby-Sessoms SL; Hubbard RC
J Clin Pharmacol; 2001 Oct; 41(10):1111-9. PubMed ID: 11583480
[TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetics and in vitro/ex vivo cyclooxygenase selectivity of parecoxib and its active metabolite valdecoxib in cats.
Kim TW; Vercelli C; Briganti A; Re G; Giorgi M
Vet J; 2014 Oct; 202(1):37-42. PubMed ID: 25135338
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular safety of the cyclooxygenase-2 selective inhibitors parecoxib and valdecoxib in the postoperative setting: an analysis of integrated data.
Schug SA; Joshi GP; Camu F; Pan S; Cheung R
Anesth Analg; 2009 Jan; 108(1):299-307. PubMed ID: 19095866
[TBL] [Abstract][Full Text] [Related]
16. Effective treatment of laparoscopic cholecystectomy pain with intravenous followed by oral COX-2 specific inhibitor.
Joshi GP; Viscusi ER; Gan TJ; Minkowitz H; Cippolle M; Schuller R; Cheung RY; Fort JG
Anesth Analg; 2004 Feb; 98(2):336-342. PubMed ID: 14742366
[TBL] [Abstract][Full Text] [Related]
17. The effect of mild and moderate hepatic impairment on the pharmacokinetics of valdecoxib, a selective COX-2 inhibitor.
Sarapa N; Britto MR; Mainka MB; Parivar K
Eur J Clin Pharmacol; 2005 Jun; 61(4):247-56. PubMed ID: 15887009
[TBL] [Abstract][Full Text] [Related]
18. Intravenous parecoxib rapidly leads to COX-2 inhibitory concentration of valdecoxib in the central nervous system.
Mehta V; Johnston A; Cheung R; Bello A; Langford RM
Clin Pharmacol Ther; 2008 Mar; 83(3):430-5. PubMed ID: 17687276
[TBL] [Abstract][Full Text] [Related]
19. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.
Nussmeier NA; Whelton AA; Brown MT; Langford RM; Hoeft A; Parlow JL; Boyce SW; Verburg KM
N Engl J Med; 2005 Mar; 352(11):1081-91. PubMed ID: 15713945
[TBL] [Abstract][Full Text] [Related]
20. Parecoxib for parenteral analgesia in postsurgical patients.
Amabile CM; Spencer AP
Ann Pharmacother; 2004 May; 38(5):882-6. PubMed ID: 15039473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
